NuStar GP (NSH) Stock Rating Upgraded by ValuEngine

NuStar GP (NYSE:NSH) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Wednesday.

Several other equities research analysts have also recently commented on NSH. Citigroup cut NuStar GP from a “buy” rating to a “neutral” rating in a report on Friday, February 2nd. B. Riley reiterated a “neutral” rating and issued a $14.00 price objective (down from $20.00) on shares of NuStar GP in a research report on Tuesday, March 20th. Zacks Investment Research lowered NuStar GP from a “buy” rating to a “hold” rating in a research report on Saturday, February 10th. Finally, Mizuho set a $16.00 price objective on NuStar GP and gave the stock a “hold” rating in a research report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $19.25.

NYSE:NSH opened at $11.75 on Wednesday. NuStar GP has a one year low of $10.40 and a one year high of $28.20. The company has a market capitalization of $496.11, a P/E ratio of 5.85 and a beta of 1.24.



NuStar GP (NYSE:NSH) last posted its quarterly earnings results on Thursday, February 8th. The pipeline company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.12). NuStar GP had a net margin of 168.31% and a return on equity of 23.82%. The company had revenue of $10.30 million during the quarter, compared to analyst estimates of $12.68 million. research analysts forecast that NuStar GP will post 0.2 EPS for the current year.

A number of institutional investors have recently modified their holdings of NSH. BNP Paribas Arbitrage SA purchased a new position in NuStar GP in the third quarter worth approximately $103,000. JPMorgan Chase & Co. grew its position in NuStar GP by 96.9% in the third quarter. JPMorgan Chase & Co. now owns 164,659 shares of the pipeline company’s stock worth $3,540,000 after acquiring an additional 81,046 shares during the period. Ladenburg Thalmann Financial Services Inc. grew its position in NuStar GP by 97.0% in the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 36,090 shares of the pipeline company’s stock worth $795,000 after acquiring an additional 17,774 shares during the period. Atlantic Trust Group LLC grew its position in NuStar GP by 14.1% in the third quarter. Atlantic Trust Group LLC now owns 1,213,910 shares of the pipeline company’s stock worth $26,706,000 after acquiring an additional 150,000 shares during the period. Finally, Center Coast Capital Advisors LP boosted its position in shares of NuStar GP by 101.2% during the fourth quarter. Center Coast Capital Advisors LP now owns 2,366,294 shares of the pipeline company’s stock worth $37,151,000 after buying an additional 1,190,451 shares during the period. Institutional investors own 53.52% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://dakotafinancialnews.com/2018/04/13/nustar-gp-nsh-stock-rating-upgraded-by-valuengine.html.

About NuStar GP

NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for NuStar GP (NYSE:NSH)

Receive News & Ratings for NuStar GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply